CAPA has partnered with 23 patient organizations to write a letter to the Minister of Health strongly supporting the decision that Minister announced on April 14th, 2022 with regards to the Amendments to the Patented Medicines Regulations providing new tools to protect Canadians from excessive prices for patented medicines. The implementation of the new basket of comparator countries and reduced reporting requirements for those medicines at lowest risk of excessive pricing are measures that are important to the improvement of access to quality medicines while generating significant savings over the coming years, and building a sustainable healthcare system. Read this letter to the Government of Canada’s Minister Duclos on the importance of such efforts.

Powered by TranslatePress